Novo Nordisk CEO sees 15 million-patient opportunity in Medicare coverage for obesity drugs

1 month ago 25
ARTICLE AD BOX

Novo Nordisk CEO Mike Doustdar.

CNBC

Novo Nordisk

Read Entire Article